1,047 top medical experts on Hyperglycemia across 56 countries and 42 U.S. states, including 992 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Hyperglycemia: Abnormally high blood glucose level.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Glucose Metabolism Disorders (2,697) and Narrower Categories: Glucose Intolerance (2,821).
  4. Clinical Trials ClinicalTrials.gov : at least 526 including 14 Active, 329 Completed, 53 Recruiting
  5. Synonyms: Postprandial Hyperglycemia


  

        

                    


    These expert listings are for individual use without a fee. Biotechs, Pharmaceuticals, Recruiters, Consultants, Investors, Law firms, and other organizations may use this only for quick evaluations (no downloads, screen scraping or using the data) to identify the top medical experts for recruiting, advisory panels, boards, and consulting. Please contact us for licensing, customized queries, feedback and questions.

  1. Buse, John B   Endocrinology, Diabetes & Metabolism   Google Publications
    Division of Endocrinology and Metabolism, University of North Carolina School of Medicine, Chapel Hill, NC.
    Physician  Highly Cited  Highly Published  Guideline  Clinical Trial 
    Medical school: Duke University School of Medicine (MD, 1986)
    Medicare Accepted; Medicare MIPS (Merit-based Incentive Payment System) rating: 76/100
    Disclosed payments in 2021 from 12 biomedical companies, totalling $41,875, including $24,375 from  Novo Nordisk AS
    Subjects: Diabetes Mellitus, Type 2; Diabetes Mellitus, Type 1; Hypoglycemic Agents; Cystic Fibrosis; Glycated Hemoglobin A
    Categories: Drug Therapy; Therapy; Diagnosis; Metabolism; Pharmacokinetics; Prevention & Control
    Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). (2018)
    Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). (2012)

  2. Tsapas, Apostolos   Google Publications
    Second Medical Department, Aristotle University Thessaloniki, Thessaloniki, Greece.
    Scientist  Highly Cited  Guideline  Review 
    Subjects: Diabetes Mellitus, Type 2; Cardiovascular Diseases; Diabetes Mellitus, Type 1; Disease Management; Hypoglycemia
    Categories: Therapy; Drug Therapy; Epidemiology; Prevention & Control; Blood
    Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). (2018)
    Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). (2012)

  3. Inzucchi, Silvio E   Endocrinology, Diabetes & Metabolism   Google Publications
    2 Section of Endocrinology, Yale University School of Medicine , New Haven, Connecticut. Top Hospital
    Physician  Highly Cited  Highly Published  Guideline  Clinical Trial 
    Medicare MIPS (Merit-based Incentive Payment System) rating: 68/100
    Disclosed payments in 2021 from 41 biomedical companies, totalling $60,136.48, including $13,345 from  Novo Nordisk AS
    Subjects: Diabetes Mellitus, Type 2; Hypoglycemia; Hypoglycemic Agents; Diabetes Mellitus; Blood Glucose
    Categories: Drug Therapy; Epidemiology; Therapy; Therapeutic Use; Prevention & Control; Administration & Dosage
    Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). (2012)
    Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. (2015)

  4. Peters, Anne L   Endocrinology, Diabetes & Metabolism  Google Publications
    Keck School of Medicine of the University of Southern California, Los Angeles, California. Top Hospital
    Physician  Highly Cited  Guideline  Clinical Trial 
    Medicare MIPS (Merit-based Incentive Payment System) rating: 72/100
    Disclosed payments in 2021 from 33 biomedical companies, totalling $15,683.41, including $7,197.11 from  Novo Nordisk Inc
    Subjects: Diabetes Mellitus, Type 2; Diabetes Mellitus, Type 1; Hypoglycemic Agents; Insulin; Blood Glucose
    Categories: Drug Therapy; Therapy; Administration & Dosage; Diagnosis; Analysis; Epidemiology
    Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). (2012)
    Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. (2015)

  5. Bergenstal, Richard M   Endocrinology, Diabetes & Metabolism   ClinicalTrials.gov Google Publications
    International Diabetes Center Park Nicollet, Minneapolis, Minnesota.
    Physician  Highly Cited  Highly Published  Guideline  Clinical Trial 
    Disclosed payments in 2021 from 38 biomedical companies, totalling $54,990.54, including $31,710 from  Eli Lilly and Company
    Subjects: Hypoglycemia; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Blood Glucose; Hypoglycemic Agents
    Categories: Prevention & Control; Drug Therapy; Administration & Dosage; Blood; Analysis; Therapy
    Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). (2012)
    Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. (2015)

  6. Wexler, Deborah J   Internal Medicine  Google Publications
    Harvard Medical School, Boston MA, USA. Top Hospital
    Physician  Highly Cited  Guideline 
    Medical school: Yale University School of Medicine (MD, 2000)
    Medicare Accepted
    Disclosed payments in 2021 from 3 biomedical companies, totalling $5,780, including $5,780 from  Novo Nordisk AS
    Subjects: Diabetes Mellitus, Type 2; Diabetes Mellitus; Glycated Hemoglobin A; Blood Glucose; Diabetes Complications
    Categories: Therapy; Drug Therapy; Blood; Epidemiology; Metabolism; Administration & Dosage
    Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). (2018)
    2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). (2020)

  7. Diamant, Michaela  Google Publications
    VU University Medical Centre, Amsterdam, The Netherlands.
    Scientist  Highly Cited  Highly Published  Guideline  Clinical Trial 
    Subjects: Diabetes Mellitus, Type 2; Hypoglycemic Agents; Nitriles; Pyrrolidines; Adamantane
    Categories: Drug Therapy; Metabolism; Therapy; Administration & Dosage; Prevention & Control; Drug Effects
    Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). (2012)
    Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. (2015)

  8. Ferrannini, Ele  Google Publications
    CNR Institute of Clinical Physiology, Pisa, Italy.
    Scientist  Highly Cited  Highly Published  Guideline  Clinical Trial 
    Subjects: Diabetes Mellitus, Type 2; Glucose Intolerance; Insulin; Insulin-Secreting Cells; Patient-Centered Care
    Categories: Drug Therapy; Metabolism; Therapy; Administration & Dosage; Complications; Epidemiology
    Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). (2012)
    Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. (2015)

  9. Matthews, David R   Emergency Medicine  Google Publications
    Oxford Centre for Diabetes, Endocrinology and Metabolism, Churchill Hospital, Oxford, U.K. National Institute for Health Research, Oxford Biomedical Research Centre, Oxford, U.K. Harris Manchester College, University of Oxford, Oxford, U.K.
    Physician  Highly Cited  Guideline  Clinical Trial 
    Subjects: Diabetes Mellitus, Type 2; Disease Management; Adamantane; Cardiovascular Diseases; Dipeptidyl-Peptidase IV Inhibitors
    Categories: Drug Therapy; Therapeutic Use; Therapy; Epidemiology; Analogs & Derivatives; Prevention & Control
    Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). (2012)
    Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. (2015)

  10. Davies, Melanie J     ClinicalTrials.gov Google Publications
    Diabetes Research Centre, University of Leicester, Leicester, U.K.
    Physician  Highly Cited  Highly Published  Guideline  Clinical Trial 
    Subjects: Diabetes Mellitus, Type 2; Hypoglycemic Agents; Glucagon-Like Peptide-1 Receptor; Glycated Hemoglobin A; Hypoglycemia
    Categories: Therapeutic Use; Drug Therapy; Prevention & Control; Therapy; Administration & Dosage; Diagnosis
    Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). (2018)
    2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). (2020)

  11. D'Alessio, David A     ClinicalTrials.gov Google Publications
    Department of Medicine, Duke University School of Medicine, Durham, NC. Top Hospital
    Physician  Highly Cited  Guideline 
    Relevant US NIH Grant Funding: $2,019,832 over the last 5 years
    Subjects: Diabetes Mellitus, Type 2; Glucose; Incretins; Insulin-Secreting Cells; Receptors, Glucagon
    Categories: Metabolism; Therapy; Blood; Drug Therapy; Genetics; Prevention & Control
    Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). (2018)
    2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). (2020)

  12. Mathieu, Chantal    Google Publications
    Laboratory for Clinical and Experimental Endocrinology, Department of Chronic Diseases and Metabolism, KU Leuven, Leuven, Belgium.
    Physician  Highly Cited  Guideline  Clinical Trial 
    Subjects: Diabetes Mellitus, Type 2; Hypoglycemia; Hypoglycemic Agents; Blastocyst; Bone Marrow Cells
    Categories: Prevention & Control; Administration & Dosage; Drug Therapy; Blood; Therapy; Cytology
    Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). (2018)
    2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). (2020)

  13. Fradkin, Judith E   Endocrinology, Diabetes & Metabolism   Google Publications
    National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD.
    Physician  Highly Cited  Guideline 
    Subjects: Diabetes Mellitus, Type 2; Aging; Diabetes Complications; Hypoglycemia; Hypoglycemic Agents
    Categories: Drug Therapy; Prevention & Control; Therapy; Therapeutic Use
    Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). (2018)
    Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). (2018)

  14. Rossing, Peter     Google Publications
    Steno Diabetes Center Copenhagen, Gentofte, Denmark.
    Physician  Highly Cited  Guideline  Clinical Trial 
    Subjects: Diabetes Mellitus, Type 2; Diabetic Nephropathies; Hypoglycemic Agents; Insulin; Amides
    Categories: Drug Therapy; Prevention & Control; Therapeutic Use; Therapy; Administration & Dosage; Pharmacology
    Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). (2018)
    2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). (2020)

  15. Nauck, Michael A   Google Publications
    Diabetes Centre, Bad Lauterberg, Kirchberg 21, Bad Lauterberg, Harz, 37431, Germany. .
    Scientist  Highly Cited  Guideline  Clinical Trial 
    Subjects: Diabetes Mellitus, Type 2; Gastric Inhibitory Polypeptide; Hypoglycemic Agents; Insulin; Cardiovascular Diseases
    Categories: Drug Therapy; Therapy; Administration & Dosage; Therapeutic Use; Analogs & Derivatives; Blood
    Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). (2012)
    Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. (2015)

  16. Mingrone, Geltrude  Google Publications
    Fondazione Policlinico Universitario A. Gemelli Istituto di Ricovero e Cura a Carattere Scientifico IRCCS, Università Cattolica del Sacro Cuore Rome, Rome, Italy.
    Scientist  Highly Cited  Guideline  Case Reports 
    Subjects: Diabetes Mellitus, Type 2; Obesity, Morbid; COVID-19; Gastric Bypass; Glycated Hemoglobin A
    Categories: Therapy; Complications; Drug Therapy; Epidemiology; Surgery; Analysis
    Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). (2018)
    2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). (2020)

  17. Metzger, Boyd E   Google Publications
    Department of Endocrinology and Metabolism, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200127, P. R. China.
    Scientist  Highly Cited  Highly Published  Guideline 
    Subjects: Pregnancy Complications; Diabetes, Gestational; Pregnancy Outcome; Blood Glucose; Prenatal Exposure Delayed Effects
    Categories: Blood; Epidemiology; Metabolism; Diagnosis; Genetics; Complications
    International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. (2010)
    The hyperglycemia and adverse pregnancy outcome study: associations of GDM and obesity with pregnancy outcomes. (2012)

  18. Lowe, Lynn P   Google Publications
    Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611, USA. Top Hospital
    Scientist  Highly Cited  Highly Published  Guideline 
    Subjects: Pregnancy Complications; Diabetes, Gestational; Blood Glucose; Pregnancy Outcome; Prenatal Exposure Delayed Effects
    Categories: Epidemiology; Blood; Metabolism; Genetics; Diagnosis; Complications
    International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. (2010)
    The hyperglycemia and adverse pregnancy outcome study: associations of GDM and obesity with pregnancy outcomes. (2012)

  19. Umpierrez, Guillermo E     ClinicalTrials.gov Google Publications
    Division of Endocrinology, Department of Medicine, Emory University School of Medicine, Grady Memorial Hospital, Atlanta, Georgia. Top Hospital
    Physician  Highly Cited  Highly Published  Guideline  Clinical Trial 
    Subjects: Hypoglycemic Agents; Insulin; Diabetes Mellitus, Type 2; Blood Glucose; Diabetes Mellitus
    Categories: Drug Therapy; Therapeutic Use; Administration & Dosage; Therapy; Prevention & Control; Metabolism
    Management of hyperglycemia in hospitalized patients in non-critical care setting: an endocrine society clinical practice guideline. (2012)
    Guidelines for the use of an insulin infusion for the management of hyperglycemia in critically ill patients. (2012)

  20. Wender, Richard   Ophthalmology  Google Publications
    American Cancer Society, Atlanta, GA Department of Family and Community Medicine, Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA.
    Physician  Highly Cited  Guideline 
    Subjects: Diabetes Mellitus, Type 2; Cardiovascular Diseases; Disease Management; Kidney Diseases; Liver Diseases
    Categories: Drug Therapy; Therapy; Epidemiology
    Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). (2012)
    Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. (2015)

Note:
  1. Only the top 20 experts are shown. You may filter your results or use the geolocation tabs. Contact us to purchase the entire list.
These expert listings are for individual use without a fee. Biotechs, Pharmaceuticals, Recruiters, Consultants, Investors, Law firms, and other organizations may use this only for quick evaluations (no downloads or screen scraping) to identify the top medical experts for recruiting, advisory panels, boards, and consulting. Please contact us for licensing, customized queries, feedback and questions.

);